High serum uric acid is associated with increased cardio-ankle vascular index (CAVI) in healthy Japanese subjects: A cross-sectional study

Atherosclerosis

Volumn 239, Issue 1, 2015, Pages 163-168

  Nagayama, Daiji ^a,b   Yamaguchi, Takashi ^a   Saiki, Atsuhito ^a   Imamura, Haruki ^a   Sato, Yuta ^a   Ban, Noriko ^a   Kawana, Hidetoshi ^a   Nagumo, Ayako ^a   Shirai, Kohji ^a   Tatsuno, Ichiro ^a  

^a TOHO UNIVERSITY   (Japan)

^b Shin Oyama City Hospital   (Japan)

Author keywords

Cardio ankle vascular index (CAVI); Gender difference; Serum uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD VESSEL FUNCTION; BLOOD VESSEL PARAMETERS; BODY MASS; CARDIO ANKLE VASCULAR INDEX; CONFOUNDING VARIABLE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; JAPANESE (PEOPLE); MALE; PRIORITY JOURNAL; REFERENCE VALUE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ANKLE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BLOOD PRESSURE MEASUREMENT; DIASTOLE; JAPAN; MIDDLE AGED; ODDS RATIO; SYSTOLE; VASCULARIZATION; YOUNG ADULT;

ADULT; AGED; ANKLE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE DETERMINATION; CROSS-SECTIONAL STUDIES; DIASTOLE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEX FACTORS; SYSTOLE; URIC ACID; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84921466300     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.01.011     Document Type: Article

References (39)

1. Klein R., Klein B.E., Cornoni J.C., Maready J., Cassel J.C., Tyroler H.A. Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch. Intern. Med. 1973, 132(3):401-410.
2. Fessel W.J. High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am. J. Med. 1980, 68(3):401-404.
3. Burack R.C., Keller J.B., Higgins M.W. Cardiovascular risk factors and obesity: are baseline levels of blood pressure, glucose, cholesterol and uric acid elevated prior to weight gain?. J.Chron. Dis. 1985, 38(10):865-872.
4. Bengtsson C., Lapidus L., Stendahl C., Waldenström J. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med. Scand. 1988, 224(6):549-555.
5. Levine W., Dyer A.R., Shekelle R.B., Schoenberger J.A., Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in industry. J.Clin. Epidemiol. 1989, 42(3):257-267.
6. Freedman D.S., Williamson D.F., Gunter E.W., Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study. Am. J. Epidemiol. 1995, 141(7):637-644.
7. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann. Intern. Med. 1999, 131(1):7-13.
8. Kanellis J., Watanabe S., Li J.H., Kang D.H., Li P., Nakagawa T., Wamsley A., Sheikh-Hamad D., Lan H.Y., Feng L., Johnson R.J. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41(6):1287-1293.
9. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283(18):2404-2410.
10. Shirai K., Utino J., Otsuka K., Takata M. Anovel blood pressure-independent arterial wall stiffness parameter; cardioankle vascular index (CAVI). J.Atheroscler. Thromb. 2006, 13(2):101-107.
11. Matsui Y., Kario K., Ishikawa J., Eguchi K., Hoshide S., Shimada K. Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens. Res. 2004, 27:851-857.
12. Yambe T., Yoshizawa M., Saijo Y., Yamaguchi T., Shibata M., Konno S., Nitta S., Kuwayama T. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed. Pharmacother. 2004, 58:95-98.
13. Kubozono T., Miyata M., Ueyama K., Nagaki A., Otsuji Y., Kusano K., Kubozono O., Tei C. Clinical significance and reproducibility of new arterial distensibility index. Circ. J. 2007, 71(1):89-94.
14. Nakamura K., Tomaru T., Yamamura S., Miyashita Y., Shirai K., Noike H. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ. J. 2008, 72(4):598-604.
15. Noike H., Nakamura K., Sugiyama Y., Iizuka T., Shimizu K., Takahashi M., Hirano K., Suzuki M., Mikamo H., Nakagami T., Shirai K. Changes in cardio-ankle vascular index in smoking cessation. J.Atheroscler. Thromb. 2010, 17(5):517-525.
16. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J.Jpn. Diabetes Soc. 2010, 2010(53):450-467.
17. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:562-569.
18. Shirai K., Hiruta N., Song M., Kurosu T., Suzuki J., Tomaru T., Miyashita Y., Saiki A., Takahashi M., Suzuki K., Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J.Atheroscler. Thromb. 2011, 18(11):924-938.
19. Nagayama D., Endo K., Ohira M., Yamaguchi T., Ban N., Kawana H., Nagumo A., Saiki A., Oyama T., Miyashita Y., Shirai K. Effects of body weight reduction on cardio-ankle vascular index (CAVI). Obes. Res. Clin. Pract. 2013, 7(2):e139-145.
20. Ohira M., Endo K., Oyama T., Yamaguchi T., Ban N., Kawana H., Nagayama D., Nagumo A., Saiki A., Murano T., Watanabe H., Miyashita Y., Shirai K. Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70. Metabolism 2011, 60(1):878-885.
21. Miyashita Y., Saiki A., Endo K., Ban N., Yamaguchi T., Kawana H., Nagayama D., Ohira M., Oyama T., Shirai K. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic subjects with hypertension. J.Atheroscler. Thromb. 2009, 16(5):621-626.
22. Miyashita Y., Endo K., Saiki A., Ban N., Yamaguchi T., Kawana H., Nagayama D., Ohira M., Oyama T., Shirai K. Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic subjects. J.Atheroscler. Thromb. 2009, 16:539-545.
23. Miyashita Y., Endo K., Saiki A., Ban N., Nagumo A., Yamaguchi T., Kawana H., Nagayama D., Ohira M., Oyama T., Shirai K. Effect of ezetimibe monotherapy on lipid metabolism and arterial stiffness assessed by cardio-ankle vascular index in type 2 diabetic subjects. J.Atheroscler. Thromb. 2010, 17:1070-1076.
24. Nagayama D., Saiki A., Endo K., Yamaguchi T., Ban N., Kawana H., Ohira M., Oyama T., Miyashita Y., Shirai K., Nagayama D., Saiki A., Endo K., et al. Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. Int. J. Clin. Pract. 2010, 64(13):1796-1801.
25. Nagayama D., Ohira M., Saiki A., Shirai K., Tatsuno I. Sarpogrelate hydrochloride decreases cardio-ankle vascular index accompanied by increased serum lipoprotein lipase mass in type 2 diabetic patients. Int. Heart J. 2014, 55(4):337-341.
26. Kim H.J., Nam J.S., Park J.S., Cho M., Kim C.S., Ahn C.W., Kwon H.M., Hong B.K., Yoon Y.W., Cha B.S., Kim K.R., Lee H.C. Usefulness of brachial-ankle pulse wave velocity as a predictive marker of multiple coronary artery occlusive disease in Korean type 2 diabetes patients. Diabetes Res. Clin. Pract. 2009, 85(1):30-43.
27. Sugawara J., Hayashi K., Yokoi T., Cortez-Cooper M.Y., DeVan A.E., Anton M.A., Tanaka H. Brachial-ankle pulse wave velocity: an index of central arterial stiffness?. J.Hum. Hypertens. 2005, 19(5):401-406.
28. Kubota Y., Maebuchi D., Takei M., Inui Y., Sudo Y., Ikegami Y., Fuse J., Sakamoto M., Momiyama Y. Cardio-Ankle Vascular Index is a predictor of cardiovascular events. Artery Res. 2011, 5(3):91-96.
29. Wen W., Luo R., Tang X., Tang L., Huang H.X., Wen X., Hu S., Peng B. Age-related progression of arterial stiffness and its elevated positive association with blood pressure in healthy people. Atherosclerosis 2015, 238(1):147-152.
30. Odden M.C., Amadu A.R., Smit E.2, Lo L., Peralta C.A. Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002. Am. J. Kidney Dis. 2014, 64(4):550-557.
31. Antón F.M., García Puig J., Ramos T., González P., Ordás J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism 1986, 35(4):343-348.
32. Leyva F., Anker S.D., Godsland I.F., Teixeira M., Hellewell P.G., Kox W.J., Poole-Wilson P.A., Coats A.J. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur. Heart J. 1998, 19(12):1814-1822.
33. Corry D.B., Eslami P., Yamamoto K., Nyby M.D., Makino H., Tuck M.L. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J.Hypertens. 2008, 26(2):269-275.
34. McKelvey T.G., Höllwarth M.E., Granger D.N., Engerson T.D., Landler U., Jones H.P. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am. J. Physiol. 1988, 254:753-760.
35. Farquharson C.A., Butler R., Hill A., Belch J.J., Struthers A.D. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002, 106(2):221-226.
36. Pietro S., Matteo C., Maria M., Pietro A.M., Maria L.M., Salvatore N., Pasquale P., Pier S.S., Roberto P., Marco M.C. Nutraceuticals and dyslipidemia: beyond the common therapeutics. J.Funct. Foods 2014, 6:11-32.
37. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. U. S. A. 1981, 78(11):6858-6862.
38. Nieto F.J., Iribarren C., Gross M.D., Comstock G.W., Cutler R.G. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis 2000, 148(1):131-139.
39. Kuo C.F., See L.C., Luo S.F., Ko Y.S., Lin Y.S., Hwang J.S., Lin C.M., Chen H.W., Yu K.H. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) 2010, 49(1):141-146.